Evidence map›Paper›PMID 26704888›Full record

ArticleBioscience reports2015

Identification of Escherichia coli ygaQ and rpmG as novel mitomycin C resistance factors implicated in DNA repair.

Edward L Bolt, Tabitha Jenkins, Valeria Moreira Russo, Sharlene Ahmed, James Cavey, Simon D Cass

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Edward L BoltSchool of Life Sciences, The University of Nottingham, Nottingham NG72UH, U.K. ed.bolt@nottingham.ac.uk.
Tabitha JenkinsSchool of Life Sciences, The University of Nottingham, Nottingham NG72UH, U.K.
Valeria Moreira RussoSchool of Life Sciences, The University of Nottingham, Nottingham NG72UH, U.K.
Sharlene AhmedSchool of Life Sciences, The University of Nottingham, Nottingham NG72UH, U.K.
James CaveySchool of Life Sciences, The University of Nottingham, Nottingham NG72UH, U.K.
Simon D CassSchool of Life Sciences, The University of Nottingham, Nottingham NG72UH, U.K.
University of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using the ASKA (A Complete Set of Escherichia coli K-12 ORF Archive) library for genome-wide screening of E. coli proteins we identified that expression of ygaQ and rpmG promotes mitomycin C resistance (MMC(R)). YgaQ mediated MMC(R) was independent of homologous recombination involving RecA or RuvABC, but required UvrD. YgaQ is an uncharacterized protein homologous with α-amylases that we identified to have nuclease activity directed to ssDNA of 5' flaps. Nuclease activity was inactivated by mutation of two amino acid motifs, which also abolished MMC(R). RpmG is frequently annotated as a bacterial ribosomal protein, although forms an operon with MutM glycosylase and a putative deubiquitinating (DUB) enzyme, YicR. RpmG associated MMC(R) was dependent on MutM. MMC(R) from RpmG resembles DNA repair phenotypes reported for 'idiosyncratic ribosomal proteins' in eukaryotes.

Indexed as

Drug Resistance, BacterialEscherichia coli K12Escherichia coli ProteinsGene Expression Regulation, BacterialMitomycinRibosomal ProteinsEscherichia coli ProteinsMitomycinRibosomal ProteinsrpmG protein, E coliDNA repairhomologous recombinationmitomycin CrpmGygaQ

Identifiers

PMID26704888
PMCPMC4725251
OpenAlexW2284428064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.